+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bowel Management Systems Market by Product, Patient Type, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031487
  • Report
  • March 2020
  • Region: Global
  • 182 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • 3M
  • B. Braun
  • Cogentix Medical
  • Coloplast
  • Convatec
  • CR Bard (BD)
The global bowel management system market was valued at $2,510.00 million in 2018, and is expected to reach $3,596.52 million by 2026, registering a CAGR of 4.5% from 2019 to 2026. A bowel management system is designed to manage fecal inconsistence in bedridden patients and has proven to be effective even in wound management and prevention & infection control. It provides safer patient outcomes and augment ease of nursing. In addition, these systems help protect the perianal and sacral pressure areas. Various types of bowel management devices include colostomy bags, irrigation systems, and nerve modulation devices.



Availability of technological advanced devices for bowel management such as ostomy products, irrigation systems, and others; significant rise in geriatric population; and surge in fecal inconsistency related disorders such as irritable bowel syndrome are the major factors contributing to the market growth. Moreover, rise in R&D investments made by government in the healthcare sector drives the growth of the bowel management system market. However, lack of trained professionals and patient’s discomfort in using these devices hinder the growth of the market. On the contrary, the introduction of various new devices and development of the healthcare R&D facilities are expected to create lucrative opportunities in the bowel management systems market. Moreover, development of the healthcare industry and an increase in R&D activities undertaken by key players are expected to boost the market growth during the forecast period.

The global bowel management systems market is segmented based on product, patient type, end user, and region. On the basis of product, the market is divided into colostomy bags, irrigation systems, nerve modulation devices, and accessories. Depending on patient type, it is classified into adult and pediatric. By end user, the market is segregated into home care, hospitals, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • The key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product
  • Colostomy Bags
  • Irrigation Systems
  • Nerve Modulation Devices
  • Accessories

By Patient Type
  • Adult
  • Pediatric

By End User
  • Home Care
  • Hospitals
  • Ambulatory Surgery Centers

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Coloplast
  • Medtronic plc
  • 3M
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cogentix Medical
  • Axonics Modulation Technologies
  • Hollister
  • Convatec
  • Wellspect Healthcare
Frequently Asked Questions about the Global Bowel Management System Market

What is the estimated value of the Global Bowel Management System Market?

The Global Bowel Management System Market was estimated to be valued at $2510.0 million in 2018.

What is the growth rate of the Global Bowel Management System Market?

The growth rate of the Global Bowel Management System Market is 4.6%, with an estimated value of $3596.5 million by 2026.

What is the forecasted size of the Global Bowel Management System Market?

The Global Bowel Management System Market is estimated to be worth $3596.5 million by 2026.

Who are the key companies in the Global Bowel Management System Market?

Key companies in the Global Bowel Management System Market include Coloplast, Medtronic, 3M, B. Braun, CR Bard (BD), Cogentix Medical, Axonics Modulation Technologies, Hollister and Wellspecthealthcar.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • B. Braun
  • Cogentix Medical
  • Coloplast
  • Convatec
  • CR Bard (BD)

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porter’s five forces analysis
3.1. Key Findings
3.1.1. Top Investment Pockets
3.2. Top Player Positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Rise in incidence of irritable bowel syndrome
3.3.1.2. Growth in geriatric population across the globe
3.3.2. Restraints
3.3.2.1. Dearth of trained professionals
3.3.3. Opportunity
3.3.3.1. Increase in growth opportunities in emerging economies
CHAPTER 4: BOWEL MANAGEMENT SYSTEMS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Colostomy bags
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Irrigation systems
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Nerve modulation devices
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Accessories
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: BOWEL MANAGEMENT SYSTEMS MARKET, BY PATIENT TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Adult
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Pediatric
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: BOWEL MANAGEMENT SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Home care
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Ambulatory Surgery Centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
CHAPTER 7: BOWEL MANAGEMENT SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. market size and forecast, by country
7.2.3. market size and forecast, by product
7.2.4. North America market size and forecast, by patient type
7.2.5. North America market size and forecast, by end user
7.2.6. U. S.
7.2.6.1. U. S. market size and forecast, by product
7.2.6.2. U. S. market size and forecast, by patient type
7.2.6.3. U. S. market size and forecast, by end user
7.2.7. Canada
7.2.7.1. Canada market size and forecast, by product
7.2.7.2. Canada market size and forecast, by patient type
7.2.7.3. Canada market size and forecast, by end user
7.2.8. Mexico
7.2.8.1. Mexico market size and forecast, by product
7.2.8.2. Mexico market size and forecast, by patient type
7.2.8.3. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by patient type
7.3.5. Europe market size and forecast, by end user
7.3.6. Germany
7.3.6.1. Germany market size and forecast, by product
7.3.6.2. Germany market size and forecast, by patient type
7.3.6.3. Germany market size and forecast, by end user
7.3.7. UK
7.3.7.1. UK market size and forecast, by product
7.3.7.2. UK market size and forecast, by patient type
7.3.7.3. UK market size and forecast, by end user
7.3.8. Spain
7.3.8.1. Spain market size and forecast, by product
7.3.8.2. Spain market size and forecast, by patient type
7.3.8.3. Spain market size and forecast, by end user
7.3.9. Rest of Europe
7.3.9.1. Rest of Europe market size and forecast, by product
7.3.9.2. Rest of Europe market size and forecast, by patient type
7.3.9.3. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by patient type
7.4.5. Asia-Pacific market size and forecast, by end user
7.4.6. Japan
7.4.6.1. Japan market size and forecast, by product
7.4.6.2. Japan market size and forecast, by patient type
7.4.6.3. Japan market size and forecast, by end user
7.4.7. China
7.4.7.1. China market size and forecast, by product
7.4.7.2. China market size and forecast, by patient type
7.4.7.3. China market size and forecast, by end user
7.4.8. India
7.4.8.1. India market size and forecast, by product
7.4.8.2. India market size and forecast, by patient type
7.4.8.3. India market size and forecast, by end user
7.4.9. Rest of Asia-Pacific
7.4.9.1. Rest of Asia-Pacific market size and forecast, by product
7.4.9.2. Rest of Asia-Pacific market size and forecast, by patient type
7.4.9.3. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by patient type
7.5.5. LAMEA market size and forecast, by end user
7.5.6. Brazil
7.5.6.1. Brazil market size and forecast, by product
7.5.6.2. Brazil market size and forecast, by patient type
7.5.6.3. Brazil market size and forecast, by end user
7.5.7. South Africa
7.5.7.1. South Africa market size and forecast, by product
7.5.7.2. South Africa market size and forecast, by patient type
7.5.7.3. South Africa market size and forecast, by end user
7.5.8. Saudi Arabia
7.5.8.1. Saudi Arabia market size and forecast, by product
7.5.8.2. Saudi Arabia market size and forecast, by patient type
7.5.8.3. Saudi Arabia market size and forecast, by end user
7.5.9. Rest of LAMEA
7.5.9.1. Rest of LAMEA market size and forecast, by product
7.5.9.2. Rest of LAMEA market size and forecast, by patient type
7.5.9.3. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Axonics Modulation Technologies Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Beckton Dickson and Company (C. R. Bard)
8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Coloplast Corp
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. ConvaTech
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Dentsply Sirona (Wellspect healthcare)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Hollister Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. Laborie Inc. (Cogentix)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. Medtronic Plc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10.3M Company
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • B. Braun
  • Cogentix Medical
  • Coloplast
  • Convatec
  • CR Bard (BD)
According to this report titled, 'Bowel Management Systems Market by Product, Patient Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global bowel management systems market size is expected to reach $3.59billion by 2026, registering a CAGR of 4.5% from 2019 to 2026, in terms of value.

Bowel management system is used for the management of fecal inconsistency in patients and help them keep the skin free from contaminants and infections. The device is a soft catheter and is inserted into the rectum for fecal management to contain and divert fecal waste. It is mainly used to avert fecal waste from patient’s body and contain liquid and semi-liquid stool. For instance, DIGNISHIELD advance stool management system offered by Bard, is an advanced stool management device that draws from clinical insight to mitigate damage to delicate tissue due to leakage, pressure, and friction. Further, it helps protect patients from exposure, tissue damage, and odor. The device contains a catheter tube assembly, a 60cc syringe, a collection bag, a syringe of lubricating jelly, and a biological odor eliminator.

Surge in availability of technological advanced devices for fecal management, rise in geriatric population, and surge in fecal inconsistency related disorders are the major factors thatdrive the growth of the bowel management systems market. Further, growth in awareness regarding the availability of these devices accompanied with launch of new devices addressing the many unmet needs contributes to the market growth of the bowel management system market. However, lack of trained professionals and patient’s discomfort in using these devices hinder the growth of the market. On the contrary, development of the healthcare R&D facilities is expected to create lucrative opportunities for the bowel management systems market. Moreover, development of the healthcare industry and an increase in R&D activities undertaken by the key players are expected to boost the market growth during the forecast period

By product, colostomy bags segment dominated the market in 2018 and is anticipated to continue its dominance during the forecast period. This is attributed to increased usage of these bags for the management of fecal inconsistency. The ease of availability and application of these devices further contributes to the market growth. However, irrigation systems segment is anticipated to grow at the fastest growth rate during the forecast period.

By patient type, adult patients segment accounted for the majority of bowel management systems market share in 2018, owing to the fact that the elderly population is more prone to face fecal inconsistency problem. Further, elderly people require more assistance and care in terms of inconsistency management. Therefore, significant rise in elderly population across the globe contributes to the bowel management systems market growth.

According to Onkar Sumant, Assistant Manager, Healthcare, “The surge in adoption of bowel management system for fecal inconsistence management and a rise in geriatric population drive the growth of the bowel management systems market.

KEY FINDINGS OF THE STUDY
  • By product, the colostomy bags segment accounted for the highest market share of 32% in 2018 and is anticipated to grow at the fastest rate during the forecast period.
  • By region, North America was the major shareholder and accounted for the highest share of 42% in 2018.
  • By patient type, the adult segment is expected to grow at a CAGR of 4.9% during the forecast period.
  • By end user, the hospital segment dominated the bowel management systems market in 2018 and is anticipated to maintain its dominance during the forecast period.

Comprehensive competitive analysis and profiles of major bowel management systems market players such as Coloplast, Medtronic, 3M, B. Braun, CR Bard (BD), Cogentix Medical, Axonics Modulation Technologies, Hollister, Convatec, and Wellspecthealthcare are provided in this report.
Note: Product cover images may vary from those shown
  • Coloplast
  • Medtronic
  • 3M
  • B. Braun
  • CR Bard (BD)
  • Cogentix Medical
  • Axonics Modulation Technologies
  • Hollister
  • Convatec
  • Wellspecthealthcar
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...